Quick Order Cart

Cat. No. ARG39311

DNAJC5 Knockout K562 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Pleural effusion

  • Disease:

    Chronic myeloid leukemia

The DNAJC5 Knockout K-562 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of the human chronic myelogenous leukemia cell line K-562, designed for loss-of-function studies of the DNAJC5 gene. DNAJC5 encodes cysteine string protein (CSP), a co-chaperone that interacts with Hsc70 and regulates SNARE-mediated exocytosis via SNAP-25 and syntaxin-1. This model is valuable for investigating chaperone-mediated protein homeostasis, neuronal ceroid lipofuscinosis type 4 (CLN4) mechanisms, and stress responses in a hematopoietic context. Applications include western blot, co-immunoprecipitation, and heat shock response assays to dissect CSP-dependent pathways and drug screening for protein aggregation disorders.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    K562

    Sex of Donor

    Female

    Derived From Site

    In situ; Pleural effusion

    Gene Name

    DNAJC5

    Gene Identifier

    NCBI Gene ID 80331

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC5 Knockout K-562 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population engineered for loss-of-function analysis of the DNAJC5 gene. This product comprises a heterogeneous pool of K-562 cells carrying targeted gene disruption, providing a powerful model to study DNAJC5-dependent mechanisms without the biases associated with clonal selection. The polyclonal nature ensures representation of multiple editing outcomes, enabling robust assessment of gene function in a mixed cellular context relevant to heterogeneous cancer cell populations.

The host K-562 line is a suspension lymphoblastoid cell line originally derived from a 53-year-old female with chronic myelogenous leukemia in blast crisis. K-562 cells exhibit a hematopoietic progenitor-like phenotype, expressing markers of both erythroid and myeloid lineages, and are widely used as a model system for leukemia biology and cytotoxicity assays. Their rapid growth in suspension and well-characterized signaling pathways make them a convenient and reproducible platform for gene editing and subsequent phenotypic screening in hematopoietic research.

DNAJC5 encodes cysteine string protein (CSP), a co-chaperone essential for synaptic vesicle exocytosis and protein homeostasis. CSP is regulated by heat shock factor 1 (HSF1) and cellular stress signals, and it directly interacts with Hsc70/HSPA8 and SGTA to prevent protein aggregation. Functionally, CSP chaperones SNARE proteins such as SNAP-25, syntaxin-1, and VAMP2, thereby modulating SNARE-mediated vesicle fusion. Disruption of DNAJC5 impairs this chaperoning activity, altering SNARE complex assembly and stress response pathways, which can lead to dysregulated exocytosis and proteostasis.

In the K-562 hematopoietic context, this polyclonal knockout model enables investigation of CSP functions beyond neuronal tissues, where it is most studied. The loss of CSP can reveal roles in SNARE-dependent processes that may affect leukemia cell signaling, survival, or secretory activity. Moreover, because DNAJC5 mutations are linked to neuronal ceroid lipofuscinosis type 4 (CLN4), a neurodegenerative disorder, the K-562 knockout population provides a tractable non-neuronal system to explore underlying molecular pathologies, including protein aggregation and chaperone network dysfunction, within a genetic background amenable to high-throughput manipulation.

This polyclonal knockout cell product supports a broad range of applications, including dissection of chaperone-mediated protein homeostasis, elucidation of DNAJC5-dependent stress responses, and drug screening for CLN4-related neurodegeneration. Researchers can employ western blot and RT-qPCR to confirm CSP disruption, co-immunoprecipitation to assess Hsc70 interactions, and heat shock response assays to evaluate stress pathway alterations. Additionally, flow cytometry for vesicle release markers and viability assays enable functional readouts in cytotoxicity studies. For ordering and technical inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)